Anemia management and the delay of chronic renal failure progression

Journal of the American Society of Nephrology

Volumn 14, Issue SUPPL. 2, 2003, Pages

  Rossert, Jerome ^a   Fouqueray, Bruno ^a   Boffa, Jean Jacques ^a  

^a HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0037530338     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (51)

1. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH: Renoprotection: one or many therapies? Kidney Int 59: 1211-1226, 1999
2. Weir MR: Progressive renal and cardiovascular disease: Optimal treatment strategies. Kidney Int 62: 1482-1492, 2002
3. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657-1666, 1988
4. Fogo A, Ichikawa I: Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 9: 329-342, 1989
5. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: Is the podocyte the culprit? Kidney Int 54: 687-697, 1998
6. Neuringer JR, Brenner B M: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 22: 98-104, 1993
7. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175: 1413-1416, 1992
8. Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994
9. Brenner BM, Lawler EV, Mackenzie HS: The hyperfiltration theory: A paradigm shift in nephrology. Kidney Int 49: 1774-1777, 1996
10. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325: 1058-1062, 1991
11. Remuzzi A, Mazerska M, Gephardt GN, Novick AC, Brenner BM, Remuzzi G: Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 48: 155-162, 1995
12. Bohle A, Müller GA, Wehrmann M, Mackensen-Hean S, Xia J-C: Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides. Kidney Int 49[Suppl. 54]: S2-S9, 1996
13. De Heer E, Sijpkens YW, Verkade M, den Dulk M, Langers A, Schutrups J, Bruijn JA, van Es LA: Morphometry of interstitial fibrosis. Nephrol Dial Transplant 15[Suppl 6]: 72-73, 2000
14. Gandhi M, Olson JL, Meyer TW: Contribution of tubular injury to loss of remnant kidney function. Kidney Int 54: 1157-1165, 1998
15. Marcussen N: Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression. Nephrol Dial Transplant 15[Suppl 6]: 74-75, 2000
16. Kang DH, Kanellis J, Hugo C, Truong L, Anderson S, Kerjaschki D, Schreiner GF, Johnson RJ: Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13: 806-816, 2002
17. Seron D, Alexopulos E, Raftery MJ, Hartley B, Cameron JS: Number of interstitial capillary cross-section assessed by monoclonal antibodies: Relation to interstitial damage. Nephrol Dial Transplant 5: 889-893, 1990
18. Bohle A, Macensen-Haen S, Wehrmann M: Significance of post-glomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19: 191-195, 1996
19. Schrier RW, Shapiro JI, Chan L, Harris DC: Increased nephron oxygen consumption: Potential role in progression of chronic renal disease. Am J Kidney Dis 23: 176-182, 1994
20. Fine LG, Ong CM, Norman JT: Mechanisms of tubulointerstitial injury in progressive renal diseases. Eur J Clin Invest 23: 259-265, 1993
21. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002
22. Eddy AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996
23. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
24. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 52: 637-647, 1997
25. Falanga V, Martin TA, Takagi H, Kirsner RS, Helfman T, Pardes J, Ochoa MS: Low oxygen tension increases mRNA levels of alpha 1 (I) procollagen in human dermal fibroblasts. J Cell Physiol 157: 408-412, 1993
26. 2 through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002
27. Geesin JC, Hendricks LJ, Falkenstein PA, Gordon JS, Berg RA: Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 290: 127-132, 1991
28. Houglum K, Brenner DA, Chojkier M: d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation. J Clin Invest 87: 2230-2235, 1991
29. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME: Redox regulation of renal DNA synthesis, transforming growth factor-beta 1 and collagen gene expression. Kidney Int 53: 367-381, 1998
30. Eddy AA: Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int 53: 1182-1189, 1998
31. Norman JT, Clark IM, Garcia PL: Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351-2366, 2000
32. Grune T, Sommerburg O, Siems WG: Oxidative stress in anemia. Clin Nephrol 53[Suppl 1]: S18-S22, 2000
33. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa β signalling cascades. Nature 412: 641-647, 2001
34. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL: Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88: 1576-1582, 1996
35. De Maria R, Zeuner A, Eramo A, Domenichelli C, Bonci D, Grignani F, Srinivasula SM, Alnemri ES, Testa U, Peschle C: Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1. Nature 401: 489-493, 1999
36. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci (USA) 97: 10526-10531, 2000
37. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P: Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci (USA) 98: 4044-4049, 2001
38. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E, Cerami A, Brines M: Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci (USA) 99: 2258-2263, 2002
39. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, Calapai G, De Vico G, Piedimonte G, Salpietro FM, Tomasello F: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci (USA) 99: 5627-5631, 2002
40. Carlini RG, Alonzo EJ, Dominguez J, Blanca I, Weisinger JR, Rothstein M, Bellorin-Font E: Effect of recombinant human erythropoietin on endothelial cell apoptosis. Kidney Int 55: 546-553, 1999
41. Akimoto T, Kusano E, Inaba T, Iimura O, Takahashi H, Ikeda H, Ito C, Ando Y, Ozawa K, Asano Y: Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int 58: 269-282, 2000
42. Westenfelder C, Biddle DL, Baranowski RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 55: 808-820, 1999
43. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ: Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res 51: 472-478, 2002
44. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F: Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93: 2627-2636, 1999
45. Fine LG, Bandyopadhay D, Norman JT: Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 57[Suppl 75]: S22-S26, 2000
46. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Skill NJ, Haylor JL, El Nahas AM: Expression of apoptosis-related genes and proteins in experimental chronic renal scarring. J Am Soc Nephrol 12: 275-288, 2001
47. Kagedal K, Johansson U, Ollinger K: The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15: 1592-1594, 2001
48. Yang B, Johnson TS, Thomas GL, Watson PF, Wagner B, Nahas AM: Apoptosis and caspase-3 in experimental anti-glomerular basement membrane nephritis. J Am Soc Nephrol 12: 485-495, 2001
49. Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW, Shadur CA, Benz RL, Teehan BP, Revicki DA, Sarokhan BJ, Abels RI: Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24: 777-784, 1994
50. Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77: 176-185, 1997
51. Jungers P, Choukroun G, Oualim Z, Robino C, Nguyen AT, Man NK: Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients. Nephrol Dial Transplant 16: 307-312, 2001